Brain distribution of genes related to changes in locomotor activity

Physiology and Behavior

Volumn 99, Issue 5, 2010, Pages 618-626

  Mignogna, Pasquale ^a   Viggiano, Davide ^a  

^a UNIVERSITY OF MOLISE   (Italy)

Author keywords

Exploration; Knockout; Locomotor activity; Mice; MRNA expression

Indexed keywords

AGED; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN FUNCTION; BRAIN LEVEL; CELL FUNCTION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; HIPPOCAMPUS; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; BRAIN; DATABASES, FACTUAL; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; SEX FACTORS;

EID: 77950368933     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.01.026     Document Type: Article

References (129)

1. Feder A., Nestler E.J., Charney D.S. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009, 10:446-457.
2. Tretter F., Albus M. Systems biology and psychiatry - modeling molecular and cellular networks of mental disorders. Pharmacopsychiatry 2008, 41(Suppl 1):S2-S18.
3. Lombroso C. L' uomo di Genio in Rapporto alla psichiatria, alla storia ed all'estetica 1888, Torino.
4. Gould S.J. The ape in some of us: criminal anthropology. The Mismeasure of Man 1981, WW. Norton & Co, New York.
5. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science 1999, 284:1670-1672.
6. Crusio W.E., Goldowitz D., Holmes A., Wolfer D. Standards for the publication of mouse mutant studies. Genes Brain Behav 2008, 8:1-4.
7. Anagnostopoulos A.V., Mobraaten L.E., Sharp J.J., Davisson M.T. Transgenic and knockout databases: behavioral profiles of mouse mutants. Physiol Behav 2001, 73:675-689.
8. Hancock J.M., Adams N.C., Aidinis V., Blake A., Bogue M., Brown S.D., et al. Mouse Phenotype Database Integration Consortium: integration [corrected] of mouse phenome data resources. Mamm Genome 2007, 18:157-163.
9. Richter S.H., Garner J.P., Wurbel H. Environmental standardization: cure or cause of poor reproducibility in animal experiments?. Nat Methods 2009, 6:257-261.
10. Curtis K.S., Krause E.G. Sex differences in physiology and behavior: focus on central actions of ovarian hormones. Physiol Behav 2009, 97:141-142.
11. Thomas M.B., Hu M., Lee T.M., Bhatnagar S., Becker J.B. Sex-specific susceptibility to cocaine in rats with a history of prenatal stress. Physiol Behav 2009, 97:270-277.
12. Arndt S.S., Laarakker M.C., van Lith H.A., van der Staay F.J., Gieling E., Salomons A.R., et al. Individual housing of mice - impact on behaviour and stress responses. Physiol Behav 2009, 97:385-393.
13. Viggiano D. The hyperactive syndrome: metaanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity. Behav Brain Res 2008, 194:1-14.
14. Ng L., Bernard A., Lau C., Overly C.C., Dong H.W., Kuan C., et al. An anatomic gene expression atlas of the adult mouse brain. Nat Neurosci 2009, 12:356-362.
15. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 2002, 99:4465-4470.
16. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004, 101:6062-6067.
17. Blednov Y.A., Stoffel M., Cooper R., Wallace D., Mane N., Harris R.A. Hyperactivity and dopamine D1 receptor activation in mice lacking girk2 channels. Psychopharmacology (Berl) 2002, 159:370-378.
18. Nonogaki K., Abdallah L., Goulding E.H., Bonasera S.J., Tecott L.H. Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. Diabetes 2003, 52:315-320.
19. Wolfer D.P., Stagljar-Bozicevic M., Errington M.L., Lipp H.P. Spatial memory and learning in transgenic mice: fact or artifact?. News Physiol Sci 1998, 13:118-123.
20. Smith K.S., Morrell J.I. Comparison of infant and adult rats in exploratory activity, diurnal patterns, and responses to novel and anxiety-provoking environments. Behav Neurosci 2007, 121:449-461.
21. Mack J.T., Beljanski V., Soulika A.M., Townsend D.M., Brown C.B., Davis W., et al. "Skittish" abca2 knockout mice display tremor, hyperactivity, and abnormal myelin ultrastructure in the central nervous system. Mol Cell Biol 2007, 27:44-53.
22. Khan Z., Jinnah H.A. Paroxysmal dyskinesias in the lethargic mouse mutant. J Neurosci 2002, 22:8193-8200.
23. Espallergues J., Galvan L., Sabatier F., Rana-Poussine V., Maurice T., Chatonnet A. Behavioral phenotyping of heterozygous acetylcholinesterase knockout (AChE+/-) mice showed no memory enhancement but hyposensitivity to amnesic drugs. Behav Brain Res 2010, 206:263-273.
24. Tanaka K., Shintani N., Hashimoto H., Kawagishi N., Ago Y., Matsuda T., et al. Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 2006, 26:5091-5097.
25. Fujii H., Ishihama T., Ago Y., Shintani N., Kakuda M., Hashimoto H., et al. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice. Peptides 2007, 28:1674-1679.
26. Weinshenker D., Miller N.S., Blizinsky K., Laughlin M.L., Palmiter R.D. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals. Proc Natl Acad Sci USA 2002, 99:13873-13877.
27. Schank J.R., Ventura R., Puglisi-Allegra S., Alcaro A., Cole C.D., Liles L.C., et al. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology 2006, 31:2221-2230.
28. Juhila J., Honkanen A., Sallinen J., Haapalinna A., Korpi E.R., Scheinin M. a2A-adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice. Eur J Pharmacol 2005, 517:74-83.
29. Miller C.L., Burmeister M., Stevens K.E. Hippocampal auditory gating in the hyperactive mocha mouse. Neurosci Lett 1999, 276:57-60.
30. Le Niculescu H., McFarland M.J., Ogden C.A., Balaraman Y., Patel S., Tan J., et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:134-166.
31. Nakajima R., Takao K., Huang S.M., Takano J., Iwata N., Miyakawa T., et al. Comprehensive behavioral phenotyping of calpastatin-knockout mice. Mol Brain 2008, 1:7.
32. D'Hooge R., Van Dam D., Franck F., Gieselmann V., De Deyn P.P. Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy. Brain Res 2001, 907:35-43.
33. Yamaguchi H., Aiba A., Nakamura K., Nakao K., Sakagami H., Goto K., et al. Dopamine D2 receptor plays a critical role in cell proliferation and proopiomelanocortin expression in the pituitary. Genes Cells 1996, 1:253-268.
34. Busquet P., Khoi N.N., Schmid E., Tanimoto N., Seeliger M.W., Ben Yosef T., et al. CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. Int J Neuropsychopharmacol 2009, 1-15.
35. Moseley A.E., Williams M.T., Schaefer T.L., Bohanan C.S., Neumann J.C., Behbehani M.M., et al. Deficiency in Na, K-ATPase alpha isoform genes alters spatial learning, motor activity, and anxiety in mice. J Neurosci 2007, 27:616-626.
36. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 1997, 90:991-1001.
37. Morellini F., Lepsveridze E., Kahler B., Dityatev A., Schachner M. Reduced reactivity to novelty, impaired social behavior, and enhanced basal synaptic excitatory activity in perforant path projections to the dentate gyrus in young adult mice deficient in the neural cell adhesion molecule CHL1. Mol Cell Neurosci 2007, 34:121-136.
38. Pratte M., Jamon M. Impairment of novelty detection in mice targeted for the Chl1 gene. Physiol Behav 2009, 97:394-400.
39. Chen C., Rainnie D.G., Greene R.W., Tonegawa S. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science 1994, 266:291-294.
40. Sgado P., Alberi L., Gherbassi D., Galasso S.L., Ramakers G.M., Alavian K.N., et al. Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc Natl Acad Sci USA 2006, 103:15242-15247.
41. Bainbridge N.K., Koselke L.R., Jeon J., Bailey K.R., Wess J., Crawley J.N., et al. Learning and memory impairments in a congenic C57BL/6 strain of mice that lacks the M2 muscarinic acetylcholine receptor subtype. Behav Brain Res 2008, 190:50-58.
42. Miyakawa T., Yamada M., Duttaroy A., Wess J. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 2001, 21:5239-5250.
43. Gerber D.J., Sotnikova T.D., Gainetdinov R.R., Huang S.Y., Caron M.G., Tonegawa S. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA 2001, 98:15312-15317.
44. Marubio L.M., Gardier A.M., Durier S., David D., Klink R., Arroyo-Jimenez M.M., et al. Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J NeuroSci 2003, 17:1329-1337.
45. Kaga Y., Shoemaker W.J., Furusho M., Bryant M., Rosenbluth J., Pfeiffer S.E., et al. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci 2006, 26:12339-12350.
46. Singh P., Cobb S., Rengifo-Cam W., Deng X., Willis W., Li Q. Locomotor activity and behavior of mutant mice deleted for gastrin gene expression. J Physiol Pharmacol 2004, 55:269-278.
47. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 1994, 79:729-742.
48. Karasinska J.M., George S.R., Cheng R., O'Dowd B.F. Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur J NeuroSci 2005, 22:1741-1750.
49. Duvoisin R.M., Zhang C., Pfankuch T.F., O'Connor H., Gayet-Primo J., Quraishi S., et al. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur J NeuroSci 2005, 22:425-436.
50. Chavez C., Gogos A., Jones M.E., Van den B.M. Psychotropic drug-induced locomotor hyperactivity and prepulse inhibition regulation in male and female aromatase knockout (ArKO) mice: role of dopamine D1 and D2 receptors and dopamine transporters. Psychopharmacology (Berl) 2009, 206:267-279.
51. Fadda P., Bedogni F., Fresu A., Collu M., Racagni G., Riva M.A. Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission. Biol Psychiatry 2007, 62(3):235-242.
52. Mori T., Ito S., Kuwaki T., Yanagisawa M., Sawaguchi T. Monoaminergic neuronal changes in orexin deficient mice. Neuropharmacology 2009.
53. Poirier R., Cheval H., Mailhes C., Charnay P., Davis S., Laroche S. Paradoxical role of an egr transcription factor family member, egr2/krox20, in learning and memory. Front Behav Neurosci 2007, 1:6.
54. Shin D.M., Korada S., Raballo R., Shashikant C.S., Simeone A., Taylor J.R., et al. Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice. J Neurosci 2004, 24:2247-2258.
55. Acevedo S.F., Ohtsu H., Benice T.S., Rizk-Jackson A., Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res 2006, 1071:113-123.
56. Dere E., Souza-Silva M.A., Spieler R.E., Lin J.S., Ohtsu H., Haas H.L., et al. Changes in motoric, exploratory and emotional behaviours and neuronal acetylcholine content and 5-HT turnover in histidine decarboxylase-KO mice. Eur J NeuroSci 2004, 20:1051-1058.
57. Polter A., Yang S., Zmijewska A.A., van Groen T., Paik J.H., Depinho R.A., et al. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation. Biol Psychiatry 2009, 65:150-159.
58. Ventura R., Pascucci T., Catania M.V., Musumeci S.A., Puglisi-Allegra S. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 2004, 15:433-442.
59. Zanettini C., Carola V., Lo I.L., Moles A., Gross C., D'Amato F.R. Postnatal handling reverses social anxiety in serotonin receptor 1A knockout mice. Genes Brain Behav 2009, PMID: 19740091.
60. Bontekoe C.J., McIlwain K.L., Nieuwenhuizen I.M., Yuva-Paylor L.A., Nellis A., Willemsen R., et al. Knockout mouse model for Fxr2: a model for mental retardation. Hum Mol Genet 2002, 11:487-498.
61. Deacon R.M., Brook R.C., Meyer D., Haeckel O., Ashcroft F.M., Miki T., et al. Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2. Physiol Behav 2006, 87:723-733.
62. Lu X., Ross B., Sanchez-Alavez M., Zorrilla E.P., Bartfai T. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides 2008, 42:387-397.
63. Vacher C.M., Gassmann M., Desrayaud S., Challet E., Bradaia A., Hoyer D., et al. Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. J Neurochem 2006, 97:979-991.
64. Umemori H., Ogura H., Tozawa N., Mikoshiba K., Nishizumi H., Yamamoto T. Impairment of N-methyl-d-aspartate receptor-controlled motor activity in LYN-deficient mice. Neuroscience 2003, 118:709-713.
65. Frisch C., De Souza Silva M.A., Sohl G., Guldenagel M., Willecke K., Huston J.P., et al. Stimulus compleity dependent memory impairment and changes in motor performance after deletion of the neuronal gap junction protein connexin36 in mice. Behav Brain Res 2005, 157:177-185.
66. Gassmann M., Shaban H., Vigot R., Sansig G., Haller C., Barbieri S., et al. Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J Neurosci 2004, 24:6086-6097.
67. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
68. Abbas T., Faivre E., Holscher C. Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease. Behav Brain Res 2009, 205:265-271.
69. Yee B.K., Keist R., von Boehmer L., Studer R., Benke D., Hagenbuch N., et al. A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 2005, 102:17154-17159.
70. Karl T., Duffy L., Herzog H. Behavioural profile of a new mouse model for NPY deficiency. Eur J NeuroSci 2008, 28:173-180.
71. Endo S., Shutoh F., Dinh T.L., Okamoto T., Ikeda T., Suzuki M., et al. Dual involvement of G-substrate in motor learning revealed by gene deletion. Proc Natl Acad Sci USA 2009, 106:3525-3530.
72. Metz G.A., Schwab M.E. Behavioral characterization in a comprehensive mouse test battery reveals motor and sensory impairments in growth-associated protein-43 null mutant mice. Neuroscience 2004, 129:563-574.
73. Iwamoto T., Okumura S., Iwatsubo K., Kawabe J., Ohtsu K., Sakai I., et al. Motor dysfunction in type 5 adenylyl cyclase-null mice. J Biol Chem 2003, 278:16936-16940.
74. Moy S.S., Nonneman R.J., Young N.B., Demyanenko G.P., Maness P.F. Impaired sociability and cognitive function in Nrcam-null mice. Behav Brain Res 2009, 205:123-131.
75. Theis M., Jauch R., Zhuo L., Speidel D., Wallraff A., Doring B., et al. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J Neurosci 2003, 23:766-776.
76. Mitchell H.A., Ahern T.H., Liles L.C., Javors M.A., Weinshenker D. The effects of norepinephrine transporter inactivation on locomotor activity in mice. Biol Psychiatry 2006, 60:1046-1052.
77. Dziedzicka-Wasylewska M., Faron-Gorecka A., Kusmider M., Drozdowska E., Rogoz Z., Siwanowicz J., et al. Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 2006, 31:2424-2432.
78. Horii Y., Yamasaki N., Miyakawa T., Shiosaka S. Increased anxiety-like behavior in neuropsin (kallikrein-related peptidase 8) gene-deficient mice. Behav Neurosci 2008, 122:498-504.
79. Karlsson R.M., Tanaka K., Heilig M., Holmes A. Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol Psychiatry 2008, 64:810-814.
80. Holmes A., Murphy D.L., Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 2002, 161:160-167.
81. Kalueff A.V., Jensen C.L., Murphy D.L. Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice. Brain Res 2007, 1169:87-97.
82. Kalueff A.V., Fox M.A., Gallagher P.S., Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav 2007, 6:389-400.
83. Basso A.M., Bratcher N.A., Harris R.R., Jarvis M.F., Decker M.W., Rueter L.E. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav Brain Res 2009, 198:83-90.
84. Cowen M.S., Schroff K.C., Gass P., Sprengel R., Spanagel R. Neurobehavioral effects of alcohol in AMPA receptor subunit (GluR1) deficient mice. Neuropharmacology 2003, 45:325-333.
85. Viollet C., Vaillend C., Videau C., Bluet-Pajot M.T., Ungerer A., L'Heritier A., et al. Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. Eur J NeuroSci 2000, 12:3761-3770.
86. Luvisetto S., Basso E., Petronilli V., Bernardi P., Forte M. Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D. Neuroscience 2008, 155:585-596.
87. Dorval K.M., Wigg K.G., Crosbie J., Tannock R., Kennedy J.L., Ickowicz A., et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 2007, 6:444-452.
88. Duncan G.E., Moy S.S., Lieberman J.A., Koller B.H. Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 2006, 85:481-491.
89. Viggiano D., Ruocco L.A., Arcieri S., Sadile A.G. Involvement of norepinephrine in the control of activity and attentive processes in animal models of attention deficit hyperactivity disorder. Neural Plast 2004, 11:133-149.
90. Hommel J.D., Sears R.M., Georgescu D., Simmons D.L., DiLeone R.J. Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 2003, 9:1539-1544.
91. Salahpour A., Medvedev I.O., Beaulieu J.M., Gainetdinov R.R., Caron M.G. Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals. Biol Psychiatry 2007, 61:65-69.
92. Kobayashi K., Morita S., Sawada H., Mizuguchi T., Yamada K., Nagatsu I., et al. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice. J Biol Chem 1995, 270:27235-27243.
93. Hnasko T.S., Perez F.A., Scouras A.D., Stoll E.A., Gale S.D., Luquet S., et al. Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia. Proc Natl Acad Sci USA 2006, 103:8858-8863.
94. Smith C.M., Lawrence A.J., Sutton S.W., Gundlach A.L. Behavioral phenotyping of mixed background (129 S5:B6) relaxin-3 knockout mice. Ann N Y Acad Sci 2009, 1160:236-241.
95. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006, 26:9022-9029.
96. Wilcoxon J.S., Nadolski G.J., Samarut J., Chassande O., Redei E.E. Behavioral inhibition and impaired spatial learning and memory in hypothyroid mice lacking thyroid hormone receptor alpha. Behav Brain Res 2007, 177:109-116.
97. Chiu C.S., Brickley S., Jensen K., Southwell A., Mckinney S., Cull-Candy S., et al. GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. J Neurosci 2005, 25:3234-3245.
98. Balogh S.A., McDowell C.S., Denenberg V.H. Behavioral characterization of mice lacking the ubiquitin ligase UBR1 of the N-end rule pathway. Genes Brain Behav 2002, 1:223-229.
99. Lamberty Y., Detrait E., Leclercq K., Michel A., De Ryck M. Behavioural phenotyping reveals anxiety-like features of SV2A deficient mice. Behav Brain Res 2009, 198:329-333.
100. Cryns K., Shamir A., Van Acker N., Levi I., Daneels G., Goris I., et al. IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology 2008, 33:674-684.
101. Burne T.H., McGrath J.J., Eyles D.W., Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 2005, 157:299-308.
102. Joho R.H., Street C., Matsushita S., Knopfel T. Behavioral motor dysfunction in Kv3-type potassium channel-deficient mice. Genes Brain Behav 2006, 5:472-482.
103. Espinosa F., Marks G., Heintz N., Joho R.H. Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels. Genes Brain Behav 2004, 3:90-100.
104. Peters H.C., Hu H., Pongs O., Storm J.F., Isbrandt D. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 2005, 8:51-60.
105. Engel S.R., Creson T.K., Hao Y., Shen Y., Maeng S., Nekrasova T., et al. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry 2009, 14:448-461.
106. Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., et al. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 2005, 25:914-922.
107. Fradley R.L., O'Meara G.F., Newman R.J., Andrieux A., Job D., Reynolds D.S. STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 2005, 163:257-264.
108. Begou M., Brun P., Bertrand J.B., Job D., Schweitzer A., D'Amato T., et al. Post-pubertal emergence of alterations in locomotor activity in stop null mice. Synapse 2007, 61:689-697.
109. Kassed C.A., Herkenham M. NF-kappaB p50-deficient mice show reduced anxiety-like behaviors in tests of exploratory drive and anxiety. Behav Brain Res 2004, 154:577-584.
110. Gilbert F., Morissette M., St Hilaire M., Paquet B., Rouillard C., Di Paolo T., et al. Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatry 2006, 60:538-547.
111. Jiang C., Wan X., He Y., Pan T., Jankovic J., Le W. Age-dependent dopaminergic dysfunction in Nurr1 knockout mice. Exp Neurol 2005, 191:154-162.
112. Eells J.B., Lipska B.K., Yeung S.K., Misler J.A., Nikodem V.M. Nurr1-null heterozygous mice have reduced mesolimbic and mesocortical dopamine levels and increased stress-induced locomotor activity. Behav Brain Res 2002, 136:267-275.
113. Backman C., You Z.B., Perlmann T., Hoffer B.J. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine. Behav Brain Res 2003, 143:95-100.
114. Gerlai R., Pisacane P., Erickson S. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res 2000, 109:219-227.
115. Vitali R., Clarke S. Improved rotorod performance and hyperactivity in mice deficient in a protein repair methyltransferase. Behav Brain Res 2004, 153:129-141.
116. Tohda C., Nakanishi R., Kadowaki M. Hyperactivity, memory deficit and anxiety-related behaviors in mice lacking the p85alpha subunit of phosphoinositide-3 kinase. Brain Dev 2009, 31:69-74.
117. Valenti P., Cozzio A., Nishida N., Wolfer D.P., Sakaguchi S., Lipp H.P. Similar target, different effects: late-onset ataxia and spatial learning in prion protein-deficient mouse lines. Neurogenetics 2001, 3:173-184.
118. Katsuta K., Umemura K., Ueyama N., Matsuoka N. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils. Eur J Pharmacol 2003, 467:103-109.
119. Schmidt S., Gawlik V., Holter S.M., Augustin R., Scheepers A., Behrens M., et al. Deletion of glucose transporter GLUT8 in mice increases locomotor activity. Behav Genet 2008, 38:396-406.
120. Gainetdinov R., Wetsel W., Jones S., Levin E., Jaber M., Caron M. Role of serotonine in the paradoxical calming effect of psychostimulants on hyperactivity. Science 1999, 283:397-401.
121. Ralph-Williams R.J., Paulus M.P., Zhuang X., Hen R., Geyer M.A. Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system. Biol Psychiatry 2003, 53:352-359.
122. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 2001, 98:1982-1987.
123. Wilson M.C. Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2000, 24:51-58.
124. Jones M.D., Hess E.J. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 2003, 75:209-216.
125. Jones M.D., Hess E.J. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 2003, 75:209-216.
126. Jones M.D., Williams M.E., Hess E.J. Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant. Pharmacol Biochem Behav 2001, 68:669-676.
127. Dyck B.A., Skoblenick K.J., Castellano J.M., Ki K., Thomas N., Mishra R.K. Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia. Synapse 2009, 63:662-672.
128. Cox P.R., Fowler V., Xu B., Sweatt J.D., Paylor R., Zoghbi H.Y. Mice lacking Tropomodulin-2 show enhanced long-term potentiation, hyperactivity, and deficits in learning and memory. Mol Cell Neurosci 2003, 23:1-12.
129. Fukamauchi F., Wang Y.J., Mataga N., Kusakabe M. Paradoxical behavioral response to apomorphine in tenascin-gene knockout mouse. Eur J Pharmacol 1997, 338:7-10.